Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Postmortem-derived iPSC models in substance use disorders research
    Published on 2023-08-14
    3 years ago
  • A path to novel, effective treatments for schizophrenia
    Published on 2023-08-14
    3 years ago
  • Calcitonin receptor signal: a potential target for opioid use disorder?
    Published on 2023-08-14
    3 years ago
  • Transcranial focused ultrasound (tFUS): a promising noninvasive deep brain stimulation approach for pain
    Published on 2023-08-10
    3 years ago
  • Electrophysiological correlates of attention in the locus coeruleus–prelimbic cortex circuit during the rodent continuous performance test
    Published on 2023-08-10
    3 years ago
  • Moving beyond descriptive nosology: an argument for negative valence systems disorder
    Published on 2023-08-09
    3 years ago
  • Microbes and mental health: translating preclinical findings to the clinic
    Published on 2023-08-08
    3 years ago
« Previous 1 … 114 115 116 117 118 … 143 Next »
Journal of Psychopharmacology
  • Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP
    Published on 2020-07-10
    6 years ago
  • The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder
    Published on 2020-07-10
    6 years ago
  • Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies
    Published on 2020-07-10
    6 years ago
  • Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
    Published on 2020-07-10
    6 years ago
  • The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies
    Published on 2020-07-10
    6 years ago
  • Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression
    Published on 2020-07-09
    6 years ago
  • Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression
    Published on 2020-07-08
    6 years ago
« Previous 1 … 114 115 116 117 118 … 150 Next »
European Neuropsychopharmacology
  • P.311 Evaluation of serum vitamin B12, folate and ferritin levels in children and adolescents with anxiety disorders
    Published on 2021-02-26
    5 years ago
  • P.306 An exploration of the pro-cognitive potential of the 5-HT4 agonist, prucalopride, in the healthy human brain
    Published on 2021-02-26
    5 years ago
  • P.312 A multimetric systematic review of fMRI findings in patients with MDD receiving ECT
    Published on 2021-02-26
    5 years ago
  • P.227 Prediction of suicidal behaviour by evaluating personality traids with machine learning techniques
    Published on 2021-02-26
    5 years ago
  • P.228 Subjective experience of the environment affects the outcome of the SSRI treatment: a preclinical study
    Published on 2021-02-26
    5 years ago
  • P.229 Targeting neural plasticity in adolescent depressed-like mice to promote treatment efficacy
    Published on 2021-02-26
    5 years ago
  • P.230 Effects of online behavioural activation on depression during covid-19
    Published on 2021-02-26
    5 years ago
« Previous 1 … 114 115 116 117 118 … 168 Next »

   Pharma Pub